Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.25%
1,110.47
+13.75
+1.25%
—1,096.721,098.741,113.821,098.74——
SIXC
Communications
SIXC
Communications
SIXC
-1.19%
604.07
-7.25
-1.19%
—611.32611.32611.32603.33——
SIXE
Energy
SIXE
Energy
SIXE
+2.56%
1,201.49
+29.95
+2.56%
—1,171.541,176.151,202.381,176.15——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.01%
1,765.30
+17.67
+1.01%
—1,747.631,747.671,770.511,744.43——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
630.42
-1.07
-0.17%
—631.49631.23633.90627.95——
SIXR
Staples
SIXR
Staples
SIXR
-1.00%
841.45
-8.49
-1.00%
—849.94850.23850.23836.20——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.35%
218.83
+0.77
+0.35%
—218.06218.06219.96218.02——
SIXT
Technology
SIXT
Technology
SIXT
+1.31%
3,582.23
+46.20
+1.31%
—3,536.033,549.423,590.523,543.38——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.97%
913.89
+8.82
+0.97%
—905.07908.07916.83907.68——
SIXV
Health care
SIXV
Health care
SIXV
-0.38%
1,444.33
-5.53
-0.38%
—1,449.861,451.341,464.451,440.75——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,412.96
-17.51
-0.72%
—2,430.472,415.842,422.952,396.14——
OSUR:NASDAQ
OraSure Technologies Inc
$3.02
-1.31%
(-0.040) 1D
$2.99
-0.99% (-0.030)
After hours
Closed: May 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSUR...
Open
$3.06
High
$3.09
Low
$3.00
Mkt. cap
217.34M
Avg. vol.
411.24K
Volume
850.26K
52-wk high
$3.82
52-wk low
$2.08
EPS
-$0.94
Beta
0.89
Shares outstanding
71.97M
No. of employees
500
News stories
From sources across the web
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
FoundedDec 11, 1987
HeadquartersBethlehem, Pennsylvania, United States
SectorMedical device
Websiteorasure.com
Last report
May 6, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.24 / -$0.17
-45.00%miss
Revenue / Est. (USD)
27.92M / 27.71M
+0.79%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
31.24M
27.08M
26.76M
27.92M
Cost of goods sold
18.08M
15.31M
15.80M
16.12M
Cost of revenue
18.08M
15.31M
15.80M
16.12M
Research and development expenses
11.40M
10.11M
11.42M
13.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.05M
17.38M
15.90M
21.33M
Operating expense
30.45M
27.49M
27.32M
34.98M
Total operating expenses
48.54M
42.80M
43.12M
51.10M
Operating income
-17.29M
-15.71M
-16.35M
-23.18M
Other non operating income
-38.00K
2.20M
1.87M
1.55M
EBT including unusual items
-17.69M
-13.66M
-19.08M
-22.81M
EBT excluding unusual items
-16.96M
-13.29M
-15.32M
-22.72M
Income tax expense
2.00M
47.00K
210.00K
-432.00K
Effective tax rate
-11.30%
-0.34%
-1.10%
1.89%
Other operating expenses
-
-
-
-
Net income
-19.69M
-13.71M
-19.29M
-22.38M
Net profit margin
-63.03%
-50.63%
-72.06%
-80.13%
Earnings per share
-0.19
-0.13
-0.19
-0.24
Interest and investment income
2.07M
-
-
-
Interest expense
-
-
-
-
Net interest expenses
2.07M
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.77M
-13.26M
-13.95M
-20.84M
Gain or loss from assets sale
-
-213.00K
268.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer